Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02112513 · ClinicalTrials.gov registry record
The Use of Maternal Serum Unconjugated Estriol for Monitoring the Prevention of Neonatal Respiratory Distress Syndrome
A clinical trial of Neonatal Respiratory Distress Syndrome, sponsored by Indiana University.
- Completed
- Registry status
- 160
- Enrollment target
- 2
- Study locations
NCT02112513 is a study of Neonatal Respiratory Distress Syndrome that has completed, run by Indiana University. The registered enrollment target is 160 participants. The trial reports 2 study locations across 1 state.
The verdict
NCT02112513, a study of Neonatal Respiratory Distress Syndrome, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 160 participants
- Enrollment target
- 2
- Study locations
Study Summary
The objective of this project is to evaluate clinical significance of measuring maternal blood estriol levels, after the administration of antenatal corticosteroids to enhance lung maturity. The investigators will test for associations of the change in maternal estriol with the development of respiratory distress syndrome. The investigators are also interested in determining whether salivary estriol is a valid surrogate to estriol blood assays. In addition the investigators will correlate these changes to pharmacokinetic (PK), pharmacodynamics (PD), and pharmacogenetic measures of betamethasone administration and fetal respiratory outcome
Conditions Studied
Study Locations (2)
Indiana
- Eskenazi Hospital - Indianapolis
- Methodist Hospital - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2012-11 |
| Est. Completion | 2017-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02112513
The ClinicalTrials.gov registry entry for NCT02112513 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Neonatal Respiratory Distress Syndrome appearing as the primary indexed condition, and to 0 interventions.
NCT02112513 reports 2 study locations spanning 1 distinct geographic area - top geographies include Indiana.
Frequently Asked Questions
What is clinical trial NCT02112513 about?
NCT02112513 is a clinical study titled "The Use of Maternal Serum Unconjugated Estriol for Monitoring the Prevention of Neonatal Respiratory Distress Syndrome". The objective of this project is to evaluate clinical significance of measuring maternal blood estriol levels, after the administration of antenatal corticosteroids to enhance lung maturity. The investigators will test for associations of the change in maternal estriol with the development of respir...
What is the current status of trial NCT02112513?
This trial is currently completed. The enrollment target is 160 participants. The study started on 2012-11. Estimated completion is 2017-06-30.
What conditions does trial NCT02112513 study?
This clinical trial studies the following conditions: Neonatal Respiratory Distress Syndrome.
Who is sponsoring clinical trial NCT02112513?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02112513 being conducted?
This trial has 2 study locations across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.